Quantcast

Latest Clinical research Stories

2014-08-18 23:09:50

On August 11, the FDA advised consumers not to purchase or use Arize due to undeclared drug ingredient. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 18, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Arize. The US FDA advised consumers on August 11, not to purchase or use Arize because it...

2014-08-18 16:28:18

Second Phase 3 Registrational Study Meets Primary and All Secondary Endpoints THOUSAND OAKS, Calif., Aug. 18, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that a second placebo-controlled Phase 3 study evaluating AMG 416 for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), receiving hemodialysis, met its primary and all secondary endpoints. The primary endpoint was the proportion of patients with > 30 percent...

2014-08-18 16:23:29

LONDON, Aug. 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Inflammatory Skin Diseases-Pipeline Insights, 2014https://www.reportbuyer.com/product/2278593/-Inflammatory-Skin-Diseases-Pipeline-Insights-2014.html SUMMARYDelveInsight's," Inflammatory Skin Diseases-Pipeline Insights, 2014", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the...

2014-08-18 16:23:26

LONDON, Aug. 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Impetigo-Pipeline Insights, 2014https://www.reportbuyer.com/product/2278589/-Impetigo-Pipeline-Insights-2014.html SUMMARYDelveInsight's," Impetigo-Pipeline Insights, 2014", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Impetigo. This report...

2014-08-18 12:27:56

ELLICOTT CITY, Md., Aug. 18, 2014 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS), the trade organization representing over 1,500 clinical research sites in 37 countries, today announced INC Research, a leading, global Phase I to IV clinical research organization (CRO), will sponsor site appreciation events at the society's annual Site Solutions Summit, Oct. 10-12, 2014, on Amelia Island, Fla. and its inaugural European Summit, March 25-27, 2015, in Croatia. "We are...

2014-08-18 12:27:06

Funding Announcement Includes Three New Topic Areas of Interest WASHINGTON, Aug. 18, 2014 /PRNewswire-USNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI) today issued the third funding announcement under its Pragmatic Clinical Studies initiative, offering up to $90 million in support for studies that address practical comparative questions faced by patients, clinicians, and other healthcare decision makers. PCORI will provide up to $10 million in direct costs for studies...

2014-08-18 08:28:40

SHANGHAI, Aug. 18, 2014 /PRNewswire/ -- WuXiPharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that a manufacturing facility of WuXi's wholly owned subsidiary Shanghai SynTheAll Pharmaceutical Co. Ltd. (STA) passed an FDA inspection in July for the manufacture of the active pharmaceutical ingredient (API) for a branded commercial drug. This...

2014-08-14 23:11:14

With 15 interactive exercises, this workshop, taught by internationally renowned medical device process validation expert Dan O’Leary, is designed to provide industry best practices to achieve sustainable process validation with regulatory bodies around the world. Attendees will learn the theories of process validation and documentation and how to put them into practice. Falls Church, VA (PRWEB) August 14, 2014 Innovative Process Validation Strategies for Medical Devices: Proving Your...

2014-08-14 23:01:16

The Firm is representing numerous individuals who allegedly suffered life-threatening cardiovascular injuries prior to the 2012 NaturaLyte and GranuFlo recall. New York, NY (PRWEB) August 14, 2014 A U.S. Food and Drug Administration (FDA) initiative that allows public access to product recall information reveals that actions similar to one that has since prompted thousands of GranuFlo lawsuits (http://www.thegranuflolawsuit.com/) have increased dramatically over the past few years,...

2014-08-14 16:27:44

Company To Pursue Next Stage of Development REDWOOD CITY, Calif., Aug. 14, 2014 /PRNewswire/ -- Coherus BioSciences, Inc. ("Coherus") today announced that CHS-1420, its proposed biosimilar of adalimumab (Humira®), met the primary endpoint in a pivotal clinical pharmacokinetic (PK) similarity study that compared CHS-1420 to Humira(®) in healthy subjects. The parallel-group, single-dose study met the criteria for clinical PK similarity on all three required, prospectively defined,...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related